Agape ATP (ATPC) Competitors $1.22 +0.05 (+3.85%) As of 12:37 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock ATPC vs. MRAI, BRTX, KDLY, MGRX, SSY, OTRK, NIVF, ATIP, BGLC, and DHACShould you be buying Agape ATP stock or one of its competitors? The main competitors of Agape ATP include Marpai (MRAI), BioRestorative Therapies (BRTX), Kindly MD (KDLY), Mangoceuticals (MGRX), SunLink Health Systems (SSY), Ontrak (OTRK), NewGenIvf Group (NIVF), ATI Physical Therapy (ATIP), BioNexus Gene Lab (BGLC), and Digital Health Acquisition (DHAC). These companies are all part of the "healthcare" industry. Agape ATP vs. Marpai BioRestorative Therapies Kindly MD Mangoceuticals SunLink Health Systems Ontrak NewGenIvf Group ATI Physical Therapy BioNexus Gene Lab Digital Health Acquisition Agape ATP (NASDAQ:ATPC) and Marpai (NASDAQ:MRAI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability, community ranking, media sentiment and analyst recommendations. Do insiders & institutionals believe in ATPC or MRAI? 0.0% of Agape ATP shares are held by institutional investors. Comparatively, 49.8% of Marpai shares are held by institutional investors. 9.7% of Agape ATP shares are held by company insiders. Comparatively, 61.3% of Marpai shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more volatility and risk, ATPC or MRAI? Agape ATP has a beta of 2.31, indicating that its share price is 131% more volatile than the S&P 500. Comparatively, Marpai has a beta of 5.02, indicating that its share price is 402% more volatile than the S&P 500. Is ATPC or MRAI more profitable? Marpai has a net margin of -85.70% compared to Agape ATP's net margin of -194.09%. Marpai's return on equity of 0.00% beat Agape ATP's return on equity.Company Net Margins Return on Equity Return on Assets Agape ATP-194.09% -74.71% -56.08% Marpai -85.70%N/A -100.23% Does the MarketBeat Community favor ATPC or MRAI? Marpai received 2 more outperform votes than Agape ATP when rated by MarketBeat users. CompanyUnderperformOutperformAgape ATPN/AN/AMarpaiOutperform Votes266.67% Underperform Votes133.33% Which has higher earnings and valuation, ATPC or MRAI? Agape ATP has higher earnings, but lower revenue than Marpai. Agape ATP is trading at a lower price-to-earnings ratio than Marpai, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAgape ATP$1.35M3.64-$2.10M-$0.73-1.69Marpai$34.87M0.43-$28.75M-$2.07-0.48 Does the media favor ATPC or MRAI? In the previous week, Agape ATP and Agape ATP both had 4 articles in the media. Agape ATP's average media sentiment score of 1.52 beat Marpai's score of 0.49 indicating that Agape ATP is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Agape ATP 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Marpai 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryMarpai beats Agape ATP on 8 of the 13 factors compared between the two stocks. Remove Ads Get Agape ATP News Delivered to You Automatically Sign up to receive the latest news and ratings for ATPC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ATPC vs. The Competition Export to ExcelMetricAgape ATPHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.93M$854.99M$5.59B$7.66BDividend YieldN/A2.47%5.33%4.02%P/E Ratio-1.6947.5423.4818.53Price / Sales3.643.39374.7988.93Price / CashN/A26.1438.1734.64Price / Book1.082.666.734.10Net Income-$2.10M-$5.50M$3.20B$247.30M7 Day Performance16.51%-5.20%-5.36%-4.14%1 Month Performance22.28%-8.81%-0.10%-6.48%1 Year Performance-81.29%60.83%8.09%-2.15% Agape ATP Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATPCAgape ATP0.7084 of 5 stars$1.22+3.8%N/A-82.3%$4.85M$1.35M-1.6640Upcoming EarningsShort Interest ↓News CoveragePositive NewsGap UpMRAIMarpaiN/A$1.04-9.6%$6.00+476.9%-59.0%$15.06M$34.87M-0.39150Gap UpBRTXBioRestorative Therapies3.7904 of 5 stars$2.06+4.3%$18.00+775.9%+31.2%$14.22M$377,000.00-1.347Earnings ReportShort Interest ↓Analyst RevisionNews CoveragePositive NewsGap DownKDLYKindly MD0.6565 of 5 stars$2.11-3.4%N/AN/A$12.58M$2.88M0.00N/AEarnings ReportGap UpMGRXMangoceuticals0.6261 of 5 stars$2.97-37.6%N/A-95.1%$7.37M$755,000.00-0.513Upcoming EarningsNews CoverageHigh Trading VolumeSSYSunLink Health SystemsN/A$1.00-5.2%N/A+39.7%$7.32M$31.23M7.431,376OTRKOntrak3.0954 of 5 stars$1.61-5.6%$45.00+2,703.7%-80.5%$6.77M$11.24M-0.15250Gap UpNIVFNewGenIvf Group1.2982 of 5 stars$1.05-3.2%N/AN/A$5.51M$5.14M0.00N/ANews CoverageGap UpATIPATI Physical TherapyN/A$1.21-1.6%N/A-78.7%$5.34M$741.86M-0.075,600BGLCBioNexus Gene Lab1.1232 of 5 stars$0.28-1.4%N/A-64.6%$5.10M$9.26M0.0030Short Interest ↓DHACDigital Health AcquisitionN/A$1.21-1.6%N/A-90.5%$4.36MN/A0.002,021 Remove Ads Related Companies and Tools Related Companies MRAI Competitors BRTX Competitors KDLY Competitors MGRX Competitors SSY Competitors OTRK Competitors NIVF Competitors ATIP Competitors BGLC Competitors DHAC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ATPC) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agape ATP Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Agape ATP With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.